{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:22:09Z","timestamp":1758475329471},"reference-count":8,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2004,5,14]],"date-time":"2004-05-14T00:00:00Z","timestamp":1084492800000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2004,5]]},"abstract":"<jats:p><jats:bold>Summary:\u2003<\/jats:bold> We report a patient with focal epilepsy and latent hereditary coproporphyria who had exacerbation of clinical symptoms of porphyria under treatment with valproate and primidone and was then treated with levetiracetam without exacerbation of clinically latent porphyria.<\/jats:p>","DOI":"10.1111\/j.0013-9580.2004.00204.x","type":"journal-article","created":{"date-parts":[[2004,5,14]],"date-time":"2004-05-14T13:35:55Z","timestamp":1084541755000},"page":"559-560","source":"Crossref","is-referenced-by-count":25,"title":["Levetiracetam in Focal Epilepsy and Hepatic Porphyria: A Case Report"],"prefix":"10.1111","volume":"45","author":[{"given":"Friedemann","family":"Paul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz\u2010Joachim","family":"Meencke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,5,14]]},"reference":[{"key":"e_1_2_3_2_2","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1212\/WNL.31.4_Part_2.480","article-title":"Safety of anticonvulsants in hepatic porphyrias","volume":"31","author":"Reynolds NC","year":"1981","journal-title":"Neurology"},{"key":"e_1_2_3_3_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.1.97"},{"key":"e_1_2_3_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.30.6.588"},{"key":"e_1_2_3_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.3.594"},{"key":"e_1_2_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(99)00052-2"},{"key":"e_1_2_3_7_2","first-page":"1667","volume-title":"Dermatology","author":"Hurley HJ","year":"1992"},{"key":"e_1_2_3_8_2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0021-9258(18)96783-9","article-title":"The induction in vitro of the synthesis of delta\u2010aminolevulinic acid synthetase in chemical porphyria: a response to certain drugs, sex hormones and foreign chemicals","volume":"241","author":"Granick S","year":"1966","journal-title":"J Biol Chem"},{"key":"e_1_2_3_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2001.44200.x"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0013-9580.2004.00204.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0013-9580.2004.00204.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T01:39:33Z","timestamp":1697161173000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0013-9580.2004.00204.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["10.1111\/j.0013-9580.2004.00204.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0013-9580.2004.00204.x","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}